LifePro Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

LifePro Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$286K	Buy	+463	New	+$274K	0.18%	115

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LifePro Asset Management's TMO Position: Q3 2024 in Review

LifePro Asset Management opened a new position in Thermo Fisher Scientific (TMO) in Q3 2024: 463 shares worth $286K. The stake represents 0.18% of the portfolio and ranks #115 among its holdings.

2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

LifePro Asset Management held 463 shares of Thermo Fisher Scientific worth $286K as of Q3 2024.
Thermo Fisher Scientific was a new LifePro Asset Management position in Q3 2024.
Thermo Fisher Scientific made up 0.18% of LifePro Asset Management's portfolio in Q3 2024, its #115 holding.
2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on LifePro Asset Management's 13F filing for Q3 2024, filed 9 Oct 2024.